Compounds > azides
Page last updated: 2024-08-23

azides and Infections, Respirovirus

azides has been researched along with Infections, Respirovirus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dirr, L; El-Deeb, IM; Eveno, T; Guillon, P; von Itzstein, M1
Alymova, IV; Babu, YS; Boyd, KL; Chand, P; Portner, A; Watanabe, M1
Alymova, IV; Babu, YS; Boyd, KL; McCullers, JA; Portner, A; Takimoto, T1

Other Studies

3 other study(ies) available for azides and Infections, Respirovirus

ArticleYear
Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors.
    Viruses, 2019, 05-05, Volume: 11, Issue:5

    Topics: Antiviral Agents; Azides; Biocatalysis; Enzyme Inhibitors; Hexuronic Acids; HN Protein; Humans; Parainfluenza Virus 1, Human; Respirovirus Infections; Virus Replication

2019
Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation.
    Antiviral therapy, 2009, Volume: 14, Issue:7

    Topics: Administration, Intranasal; Animals; Azides; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hexuronic Acids; HN Protein; Humans; Macaca mulatta; Mice; Parainfluenza Virus 1, Human; Premedication; Respirovirus Infections; Treatment Outcome

2009
The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:1

    Topics: Animals; Azides; Disease Models, Animal; Hexuronic Acids; HN Protein; Humans; Lung; Mice; Parainfluenza Virus 1, Human; Pneumonia, Pneumococcal; Respirovirus Infections; Sendai virus; Streptococcus pneumoniae

2005